Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?Archived
Despite long-standing mumps vaccination programmes with high coverage in Europe, a majority of the countries analysed have in recent years experienced mumps outbreaks or failed to reach the case/100 000 population WHO control target. Preventing outbreaks and controlling mumps most likely requires several elements, including high-coverage two-dose vaccination programmes with a highly immunogenic mumps vaccine of the same strain given with 4–8 years between doses. The ﬁndings reported by this study can be useful for future planning of mumps vaccination programmes.
Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, Kriz B, Mitis G, Mossong J, Nardone A, O'Flanagan D, DE Ory F, Pistol A, Theeten H, Prosenc K, Slacikova M, Pebody R. Epidemiol Infect. 2012 Jun 12:1-16. [Epub ahead of print]
Mumps: Burden of disease in FranceArchived
19 Dec 2012 - Mumps is not a notifiable disease in France, and this study provides useful information by combining different data sources. The current incidence of mumps is somewhat higher than the average European (9 versus 3.2 per 100 000 per year) and authors sugges
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for SeronegativityArchived
16 Aug 2012 - This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.